ArticleScientific reports2015

Nelfinavir and nelfinavir analogs block site-2 protease cleavage to inhibit castration-resistant prostate cancer.

Min Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.